JetPay Corporation (NASDAQ:JTPY)
JetPay Corporation (NASDAQ:JTPY) represented a move of 0 percent or $0 per share and closed its previous day trading session at $5.05. 0 Shares were traded in the last trading session with an Average Volume of 211.26 Million Shares. The stock currently has a Market Capitalization of 79.39 Million.
JetPay Corporation engages in providing a one vendor solution for payment services, debit and credit card processing, ACH services and payroll and tax processing needs of businesses throughout the US. It offers processing services to banks, sales organizations, and merchants. The Company specializes in technology solutions for the e-commerce and card-not-present marketplace. JetPay Corporation, formerly known as Universal Business Payment Solutions Acquisition Corporation, is based in United States.
The stock traded between $1.60 and $5.29 over 1-Year time period showing its price to sales ratio of 1.19. JetPay Corporation (NASDAQ:JTPY) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $30.96 and 200-Day Simple Moving Average of $105.74. Its Price to Free Cash Flow is 27.37 and Price to Book of 0.
Analyst’s recommended the stock as 5 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, JetPay Corporation (NASDAQ:JTPY) reported its Actual EPS of $-0.23/share. The analysts offering Earnings Estimates for the company were believing that JetPay Corporation could bring EPS of $-0.22/share. The difference between Actual EPS and Estimated EPS was -0.01 Percent. Thus showing an Earnings Surprise of -4.5 Percent.
Correvio Pharma Corp. (NASDAQ:CORV)
In the last trading session, Correvio Pharma Corp. (NASDAQ:CORV) added its value by 0% closing at the price of $3.47. The stock currently has market capitalization of 119.02 Million, with average volume of 158.93 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Correvio Pharma Corp. (NASDAQ:CORV) is showing beta of -0.26. This particular value of beta suggests that Correvio Pharma Corp. (NASDAQ:CORV) has historically moved -26% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Correvio Pharma Corp. (NASDAQ:CORV) is at $-0.31.
The stock currently has RSI of 51.23. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Correvio Pharma Corp. operates as a pharmaceutical company. It develops and discovers cardiovascular drugs for the treatment of atrial arrhythmia, congestive heart failure and bacterial skin infections. The company’s product portfolio includes BRINAVESS(R), AGGRASTAT(R), ESMOCARD(R), ESMOCARDLYO(R), EXEMBOL(R) and XYDALBA(TM). Correvio Pharma Corp., formerly known as Correvio Pharma Corp., is based in Vancouver, Canada.
Correvio Pharma Corp. (NASDAQ:CORV) topped its 52-week high price of $5.24 on 08/17/18 and 52-Week Low Price of $1.31 on 02/05/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 5.78% and monthly volatility of 6.89% respectively.